Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines - Polymyxin B and Others.
Deadline: 09 Jul 2026
Posting Date: 29 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144189792
Document Ref. No.: 90081/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Acquisition of Medicines - Polymyxin B and others. UASG code: 90171 Notice from: 06/29/2026 from 08:00 to 12:00 and from 13:00 to 17:00 Proposal Delivery: from 06/29/2026 at 08:00 POLYMYXIN B, CONCENTRATION 500, 000 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 300 IRON III, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 150 SCETAMINE, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 300 ISOSORBIDE, ACTIVE INGREDIENT MONONITRATE SALT, DOSAGE 10 MG/ML, INJECTABLE SOLUTION MEDICATION TYPE Quantity: 600 PARENTERAL NUTRITION, SOL COMPOSITION. AMINO ACIDS WITHOUT GLUTAMINE, WITHOUT LIPID EMULSION, COMPONENTS MAY OR MAY NOT HAVE THE ADDITION OF: IONS CA, NA, K, CL, P, M G, OTHER COMPONENTS TRACE ELEMENTS, GLUCOSE, VITAMINS AND SELENIUM, CONCENTRATION COMPONENTS IN VARIED CONCENTRATIONS AND VOLUMES, PHARMACEUTICAL FORM SPECIALLY HANDLED INJECTABLE PREPARATION Quantity: 125 RINGER, SIMPLE COMPOSITION, SHAPE PHARMACEUTICAL INJECTABLE SOLUTION, ADDITIONAL FEATURE CLOSED SYSTEM Quantity: 1000 SODIUM CHLORIDE, CONCENTRATION 0.9%, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS CLOSED SYSTEM, ADDITIONAL CHARACTERISTICS 1 POUCH/ BOTTLE FREE PVC Quantity: 13800 DAPAGLIFLOZIN, CONCENTRATION 10 MG Quantity: 2000 TRANEXAMIC ACID, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 800 DEXAMETHASONE, DOSAGE 4 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 5000 DOBUTAMINE HYCLORHYDRATE, DOSAGE 12.5 MG/ML, INJECTABLE INDICATION Quantity: 600 ENOXAPARIN, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 FILLED SYRINGE Quantity: 3000 MORPHINE, SULFATE PRESENTATION, CONCENTRATION 0.2MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 400 NOREPINEPHRINE, CON...
Documents
Tender Notice